TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04350047

Intervention type: PROCEDURE
Intervention: Radical nephrectomy with inferior vena cava thrombectomy without thoracotomy
Description: The abdomen was accessed through a Makuuchi incision. After mobilization of the liver and assessment of the inferior vena cava infiltration (IVC), IVC was clamped below the level of the renal veins. In order to get access to the intrapericardial IVC, an incision was made through the tendon of the diaphragm and a clamp was placed first in the hepatoduodenal ligament (Pringle maneuver) and then in the endopericardial portion of the IVC, in that order. A longitudinal 3-4 cm incision was made incorporating the junction of IVC and right renal vein. After tumor removal thrombus was removed and a fine clamp was placed at the IVC just below the hepatocaval junction and immediate release of the clamping of the hepatoduodenal ligament. Total endopericardial clamp time was 4 minutes. Patients then underwent radical nephrectomy in a standard fashion with en bloc resection of the IVC thrombus.
Study: NCT02723448

Intervention type: DRUG
Group type: OTHER
Intervention: aclarubicin
Description: Aclarubicin (3 mg/m²) will be administered intravenously through a central venous access device over 1 hour for four consecutive days per 28 day cycle. There is no maximum number of cycles.
Study: NCT03109626

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: DHA

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: DHA
Study: NCT03790865

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Livoletide
Description: Daily subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Livoletide
Description: Daily subcutaneous injection

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Daily subcutaneous injection
Study: NCT00096538

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: valganciclovir
Study: NCT04633499

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social Cognition Task
Description: Two paradigms will be tested: visual perspective taking and reading the mind in the eyes.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social Cognition Task
Description: Two paradigms will be tested: visual perspective taking and reading the mind in the eyes.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social Cognition Task
Description: Two paradigms will be tested: visual perspective taking and reading the mind in the eyes.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: tDCS
Description: tDCS either over the dmPFC or the rTPJ.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tDCS
Description: tDCS either over the dmPFC or the rTPJ.
Study: NCT01634308

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Novosis(bongros/BMP-2)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bio-oss
Study: NCT04293497

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Cytology staining
Description: Two staining will be performed in cytology specimens obtained from same patient. The cytology specimen will be obtained using endoscopic ultrasound-guided fine needle aspiration. Three types of slides (direct smear, thinprep, surepath) are prepared for staining.~1. conventional cytology staining method~2. new cytology staining method using antibody of methionyl-tRNA synthetase 1
Study: NCT02171117

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: microtransplantation
Description: infusion of granulocyte colony stimulating factor (G-CSF) mobilized HLA-mismatched peripheral blood stem cells (GPBSC)

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HLA-mismatched donor peripheral stem cell infusion
Study: NCT02741375

Intervention type: DEVICE
Intervention: Somanetics 5100c (Invos oximeter cerebral/somatic Troy, MI, USA)
Description: All patients underwent at least 6-h NIRS monitoring using a Somanetics 5100c (Invos oximeter cerebral/somatic Troy, MI, USA) cerebral oximeter in order to determined cerebral oximetry changes.

Intervention type: DEVICE
Intervention: Somanetics 5100c (Invos oximeter cerebral/somatic Troy, MI, USA)
Description: All patients underwent at least 6-h NIRS monitoring using a Somanetics 5100c (Invos oximeter cerebral/somatic Troy, MI, USA) cerebral oximeter in order to determined cerebral oximetry changes.
Study: NCT01429298

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydromorphone
Description: 2 mg IV hydromorphone over to 2-3 minutes

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Attending administers IV opioid of his choosing
Study: NCT02852057

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: timolol maleate and dorzolamide hydrochloride
Description: Timolol maleate and dorzolamide hydrochloride loaded contact lenses
Study: NCT02629744

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etrolizumab
Description: Single SC dose of etrolizumab at 105 milligrams (mg) on Day 1.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Prefilled Auto-injector (Rotaject)
Description: Participants self-administered etrolizumabSC injection using a prefilled auto-injector.
Study: NCT03075189

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Whey protein supplement
Description: During hospitalization the intervention group will receive a whey protein enriched snack/meal in the morning and before bedtime. They will be given 15 gr of protein every morning, and the meal before bedtime will vary in protein content according to the individual needs. Diet registration will be carried out every day during hospitalization. At discharge, participants in the intervention will be instructed and advised with focus on consuming more protein at home.~The control group are having the ordinary hospital diet and are following normal guidelines. They are not offered the protein focused counseling at discharge.~Both groups have diet registration and testing at baseline, discharge and follow-up.
Study: NCT02581033

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nucleoside Analogue therapy
Description: Determinants of sustained virological response after discontinuation of long-term nucleoside analogue therapy in chronic hepatitis B patients.
Study: NCT00844662

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fermagate
Description: Film coated tablet 500mg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevelamer hydrochloride
Description: Tablet 800mg
Study: NCT04633993

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PCSMP
Description: This study divided the patient-centered self-management manual for patients with hypertensive nephropathy into 4 units, including: Unit 1: hypertensive nephropathy brief introduction and complications. Unit 2: dietary precautions for patients with hypertensive nephropathy. Unit 3: medication treatments for patients with hypertensive nephropathy. Unit 4: the content included stress management (emotional control, spiritual support). This program was implemented in small groups with 5-10 patients. This study used patient-centered self-management group activity manual as the tool. The group activities with 4 units lasting for 400 minutes were expected to be designed. The group activities were expected to last for 4 weeks and be implemented once per week and 100 minutes per time (including: 90 minutes of group discussion and 5-10 minutes of video-waring).
Study: NCT02182219

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIBF 1120
Study: NCT00610779

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: mixture of aromatic essential oils.
Description: 1% of mixture containing aromatic essential oils of Eucalyptus citriodora, Eucalyptus globulus, Mentha piperita, Origanum syriacum, and Rosmarinus Officinalis, spraying to the nose.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: 0.1% of Lemon VIP (Florasynth,Israel), spraying to the nose.
Study: NCT04671940

Intervention type: OTHER
Intervention: DNA Analysis
Description: Molecular analysis includes DNA analysis on the blood/saliva and on the cancer specimens from the biopsies \& subsequent resections

Intervention type: OTHER
Intervention: DNA Analysis
Description: Molecular analysis includes DNA analysis on the blood/saliva and on the cancer specimens from the biopsies \& subsequent resections
Study: NCT02086955

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nursing counseling
Description: The participants who are randomized in the intervention group receive standardized education regarding diabetic foot care. The nurse-led outpatient intervention lasts five weeks. During a period of five weeks, the participants are provided with weekly skill training, and counseling sessions on foot care. Each participant receives a foot care kit with essential foot care material and a foot care diary.
Study: NCT04385979

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Gel
Description: containing herbal Curcumin or NanoCurcumin

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Gel
Description: containing herbal Curcumin or NanoCurcumin
Study: NCT01900847

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine
Description: 0.3mg/kg ketamine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Morphine
Description: Dosage of morphine determined by treating physician

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Morphine
Description: Dosage of morphine determined by treating physician

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: placebo
Description: saline of same volume as appropriate weight based dose of ketamine
Study: NCT03072420

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Compression of the fingertip under MRI.
Description: Compression of the fingertip by a static loading on the phalanx distal of the index of the subjects; Then also a shear stress in the transverse direction of the finger. The data provided by the MRI images will be geometric information such as the thickness of the skin and its possible variation as a function of the area of the finger, the total thickness of soft tissues in compression as a function of the variation in l The angle between the axis of the phalanx and the plane of contact; Mechanical type information relating to the displacements and reaction forces, to the internal deformations of the different areas of the finger.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Compression of the fingertip under MRI.
Description: Compression of the fingertip by a static loading on the phalanx distal of the index of the subjects; Then also a shear stress in the transverse direction of the finger. The data provided by the MRI images will be geometric information such as the thickness of the skin and its possible variation as a function of the area of the finger, the total thickness of soft tissues in compression as a function of the variation in l The angle between the axis of the phalanx and the plane of contact; Mechanical type information relating to the displacements and reaction forces, to the internal deformations of the different areas of the finger.
Study: NCT00552214

Intervention type: DEVICE
Group type: OTHER
Intervention: Blood test
Description: Screening of HIV-1 RNA, HCV RNA and HBV DNA in Human Blood Donor Plasma Specimens
Study: NCT04171362

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Connective Tissue Massage
Description: Connective tissue massage (CTM) is a manipulative technique that facilitates the diagnosis and treatment of a wide range of pathologies. Observation and subsequent manipulation of the skin and subcutaneous tissues can have a beneficial effect upon tissues remote from the area of treatment.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Education
Description: Education patients were informed about migraine triggers, migraine prevention and coping strategies and exercise options. The exercises were demonstrated by the physiotherapist

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education
Description: Education patients were informed about migraine triggers, migraine prevention and coping strategies and exercise options. The exercises were demonstrated by the physiotherapist
Study: NCT00003522

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antineoplaston therapy (Atengenal + Astugenal)
Description: Patients with Cancer of the Small Intestine will receive Antineoplaston therapy (Atengenal + Astugenal).~The daily doses of A10 and AS2-1 are divided into six infusions, which are given at 4-hourly intervals. Each infusion starts with infusion of A10 and is immediately followed by infusion of AS2-1.
Study: NCT00540670

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E5555 50 mg
Description: E5555 50 mg (tablet) taken orally, once a day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E5555 100 mg
Description: E5555 100 mg (tablet) taken orally, once a day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E5555 200 mg
Description: E5555 200 mg (tablet) taken orally, once a day.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo (tablet) taken orally, once a day.
Study: NCT02132728

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Flaxseed or rice raw powder ingestion
Description: The experimental groups received isocaloric diets and different proportions of carbohydrates, and the introduction of 60g of brown flaxseed or rice raw powder. Flaxseed and raw rice were crushed weekly by minimal particle type mill and appropriate sieves for fine grinding grain with a degree to 250 mm/micrometers. After crushing flaxseed and raw rice, they were weighed in semi-analytical balance. The addition of flaxseed or raw rice powder was made in the collation (40 g added to milk) and lunch (20 g added to baked beans). The volunteers received flaxseed or rice raw powder, portioned to be used for 42 days, including the weekends.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Flaxseed or rice raw powder ingestion
Description: The experimental groups received isocaloric diets and different proportions of carbohydrates, and the introduction of 60g of brown flaxseed or rice raw powder. Flaxseed and raw rice were crushed weekly by minimal particle type mill and appropriate sieves for fine grinding grain with a degree to 250 mm/micrometers. After crushing flaxseed and raw rice, they were weighed in semi-analytical balance. The addition of flaxseed or raw rice powder was made in the collation (40 g added to milk) and lunch (20 g added to baked beans). The volunteers received flaxseed or rice raw powder, portioned to be used for 42 days, including the weekends.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Flaxseed or rice raw powder ingestion
Description: The experimental groups received isocaloric diets and different proportions of carbohydrates, and the introduction of 60g of brown flaxseed or rice raw powder. Flaxseed and raw rice were crushed weekly by minimal particle type mill and appropriate sieves for fine grinding grain with a degree to 250 mm/micrometers. After crushing flaxseed and raw rice, they were weighed in semi-analytical balance. The addition of flaxseed or raw rice powder was made in the collation (40 g added to milk) and lunch (20 g added to baked beans). The volunteers received flaxseed or rice raw powder, portioned to be used for 42 days, including the weekends.
Study: NCT02905045

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketoprofen

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Study: NCT03442244

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LEO 90100 foam
Description: Each subject has each of the 2 treatments applied at the same time on 2 different sites on the back

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle of LEO 90100 foam
Description: Each subject has each of the 2 treatments applied at the same time on 2 different sites on the back
Study: NCT02721914

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: GROUP RECEIVING MASSOTHERAPY- HYPOPRESSIVE ABDOMINAL GYMNASTIC
Description: The subjects of this group will receive an amount of eight sessions that will be applied within five weeks; four massotherapy sessions and another 4 of H.A.G. The three first weeks one session of each methodology will be applied, starting always with massotherapy (with sessions on Mondays and Thursdays or on Tuesdays and Fridays). On the fourth week a session of massotherapy will be applied on the same day as usual. And, finally, on the fifth week a session of H.A.G will be applied on the same day as massotherapy is applied.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: GROUP RECEIVING MASSOTHERAPY
Description: The sessions will be applied for 5 weeks. The first three weeks 2 sessions per week will be applied (whether on Mondays and Thursdays or Tuesdays and Fridays), and during the remaining two weeks only a session will be applied per week, on the first day of the week same as applied before.~Massotherapy technics will be applied all over the back, covering the thoracolumbar area as well as upper areas reaching the cervix and occiput.~In particular, posterosuperior iliac spines, iliac crests, ribs, shoulder girdle and the entire spine (sacral bone- lumbar area-backbones-cervical vertebrae) and its attached tissues will be worked down.~Massotherapy protocol will be applied by the physical therapist, always respecting the postural ergonomics. This enables the verticality of the body (avoiding the slopes) which makes work much easier thanks to the inertia triggered by the load transfer in the lower extremities in both sagittal and horizontal plane.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: GROUP RECEIVING HYPOPRESSIVE ABDOMINAL GYMNASTIC
Description: The subjects of this group will receive a total of 8 sessions of 30 minutes each; sessions will be applied for 5 weeks. The first three weeks 2 sessions per week will be applied (whether on Mondays and Thursdays or Tuesdays and Fridays), and during the remaining two weeks only a session will be applied per week, on the first day of the week same as applied before.~The techniques applied are an assembly of rhythm, postural and breathing exercises that have to be done in a systematically. The physical therapist will check that all of the group subjects have assimilated properly the H.A.G and the breathing patterns from the exercises protocol. If they have, then the practical session which comprises 6 hypopressive exercises, can be started.~The subjects must remain in each position between 10 and 30 seconds and repeat the exercise three times, with a rest period among each that will last at least 20 seconds.
Study: NCT03887208

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laser therapy
Description: non-ablative fractional laser therapy of skin

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Laser therapy
Description: non-ablative fractional laser therapy of skin

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous ADSC injection
Description: Subcutaneous injection of autologous ADSC

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline injection
Description: Subcutaneous Normal saline injection
Study: NCT02802696

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furosemide
Description: A bolus dose of 20mg furosemide (20mg/2mL) will be given intravenously by slow intravenous push within 60 minutes prior to the start of the red blood cell transfusion; infusion via minibag is also acceptable.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Description: A single bolus dose of 2 mL normal saline will be given intravenously immediately within 60 minutes prior to the start of the red blood cell transfusion; infusion via minibag is also acceptable.
Study: NCT04198142

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Imagery Rehearsal Therapy
Description: The Imagery Rehearsal Therapy (IRT) intervention used in this study is a short version of the treatment, consisting of 1-2 sessions.~The protocol starts with a very brief explanation of the treatment. Then the patient will be guided through an imagery exercise. The next step is to choose a nightmare. This nightmare is then rescripted to a new narrative, which is in no way distressing to the patient anymore. Subsequently, the therapist will guide the patient through an imagery exercise with the new narrative. The new narrative is then either written down or recorded. Lastly, the therapist will explain to the patient, that he or she should rehearse the new narrative daily with imagery exercises.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as Usual with dream diaries
Description: Treatment as Usual means that patients in this arm will receive usual inpatient care. Additionally, they will keep a dream diary. It has been shown in previous studies that keeping a dream diary has a positive effect on nightmares.
Study: NCT03694223

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health education delivery methods

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health education delivery methods

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Health education delivery methods
Study: NCT02207400

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate and sodium fluoride
Description: Experimental toothpaste containing sodium bicarbonate experimental dentifrice plus 1150 parts per million (ppm) fluoride as sodium fluoride

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sodium fluoride
Description: Comparator toothpaste containing 1100 ppm fluoride as sodium fluoride
Study: NCT00761371

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream
Description: Subjects were treated with imiquimod (one sachet/20 cm2), three applications per week, for up to 16 weeks, or fewer in the case of total clearance of initial warts. At the visit at the end of treatment, a second scraping of the lesion area was carried out to determine the sub-type of HPV.
Study: NCT02338401

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Omega-3 Complete
Description: Fish Oil Capsules

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Pill
Description: Olive Oil Capsules